Apolipoprotein e polymorphism - A risk factor in Romanian pregnant women with preeclampsia: Influence on serum lipoprotein levels, the degree of severity and perinatal outcome of preeclampsia

Gineco.ro

Volumn 7, Issue 3, 2011, Pages 134-140

  Procopciuc, Lucia Maria ^a   Hazi, Georgeta Maria ^a   Caracostea, Gabriela ^b   Nemeti, Georgiana ^b   Olteanu, Ileana ^a   Stamatian, Florin ^b  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Department of Gynecology   (Romania)

Author keywords

APOE genotypes; Lipoproteins levels; PCR RFLP; Preeclampsia; Romania

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MATERNAL HYPERTENSION; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84859978853     PISSN: 18414435     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and metaanalysis. BMJ 2007; 335: 974.
2. Chappell LC, Seed PT, Briley A et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187: 127-136. (Pubitemid 34800311)
3. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working Group on research on hypertension during pregnancy. Hypertension 2003; 41: 437-445. (Pubitemid 36314613)
4. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy induced hypertension. Lancet 1993; 341: 1447-51. (Pubitemid 23161452)
5. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357: 53-56. (Pubitemid 32056505)
6. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785-799. (Pubitemid 40311367)
7. Pouta A, Hartikainen AL, Sovio U et al. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension 2004; 43: 1-7.
8. Williams D Pregnancy: a stress test for life. Curr Opin Obstet Gynecol 2003; 5: 465-471. (Pubitemid 38333555)
9. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005; 366: 1797-1803. (Pubitemid 41642644)
10. Ou T, Yamakawa-Kobayashi K, Arinami T et al. Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study. Atherosclerosis 1998; 137: 23-28. (Pubitemid 28175373)
11. Ghebranious N, Ivacic L, Mallum J, Dokken C. Detection of ApoE E2, E3 and E4 alleles using MALDI-TOF mass spectrometry and the homogeneous mass-extend technology. Nucleic Acids Research 2005; 33 (17): e149.
12. Nagy B, Rigo J, Fintor L. Apolipoprotein E alleles in women with severe preeclampsia. J Clin Pathol 1998; 51: 324-5. (Pubitemid 28281006)
13. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988, 8:1-21. (Pubitemid 18049171)
14. Siest G, Pillot T, Regis-Bailly A et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995; 41: 1068-1086.
15. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 2002; 155: 487-519.
16. Song Y, Stampfer MJ, Liu S: Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 2004; 141:137-47. (Pubitemid 38937836)
17. Makkonen N, Heinonen S, Hiltunen M, Helisalmi S, Mannermaa A, Kirkinen P. Apolipoprotein E alleles in women with pre-eclampsia. J Clin Pathol. 2001; 54(8): 652-4. (Pubitemid 32756453)
18. Miettinen T. Impact of apoE phenotype on the regulation of cholesterol metabolism. Ann Med 1991; 23: 181-6.
19. Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apo E phenotype: a meta-analysis. J Lipid Res 33 1992: 447-454.
20. Gerdes LU, Gerdes C, Kervinen K et al. The apolipoprotein E allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction. A substudy of the Scandinavian Simvastatin Survival Study. Circulation 2000; 101: 1366-71. (Pubitemid 30169856)
21. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993; 342: 697-699. (Pubitemid 23279761)
22. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988: 81-21.
23. Rindler MJ, Traber MG, Esterman AL, Berseinger NA, Dancis J. Synthesis and secretion of apolipoprotein E by human placenta and choriocarcinoma cell lines. Placenta. 1991; 12: 615-624.
24. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002; 99(33): 159.
25. Agarwal M, Parveen F, Faridi RM, Phadke SR, Das V, Agrawal S. Recurrent Pregnancy Loss and Apolipoprotein E Gene Polymorphisms: A Case-Control Study from North India. American Journal of Reproductive Immunology 2010; 64: 172-178.
26. Desoye G, Schweditsch MO, Pfeiffer KP, Zechner R, Kostner GM. Correlations of hormones with lipid and lipoprotein levels during normal pregnancy and post partum. J Clin Endocrinol Metab 1987; 64:704-12. (Pubitemid 17044536)
27. Solomon CG, Seely EW. Brief review: hypertension in pregnancy: a manifestation of the insulin resistance syndrome? Hypertension 2001; 37: 232-239. (Pubitemid 32199080)
28. Kaaja R, Tikkanen M, Viinikka L, et al. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995; 85: 353-6.
29. Sattar N, Bendomir A, Berry C et al. Lipoprotein subfraction concentration in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 1997; 89: 404-8.
30. Franz H, Wendler D. A controlled study of maternal serum concentrations of lipoproteins in pregnancy-induced hypertension. Arch Gynecol Obstet 1992; 252: 81-6.
31. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancyinduced hypertension. J Clin Endocrinol Metab 2003; 88: 2393-2398. (Pubitemid 36724402)
32. Jayanta De, Mukhopadhyay AK, Saha PK. Study of serum lipid profile in pregnancy induced hipertensión. Indian Journal of Clinical Biochemistry 2006; 21 (2): 165-168. (Pubitemid 44756946)
33. Belo L, Caslake M, Gaffney D et al, Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis 2002; 162: 425-432. (Pubitemid 34457949)
34. Kinoshita M, Arai H, Fukasawa M, et al. Apolipoprotein E enhances lipid exchange between lipoproteins mediated by cholesteryl ester transfer protein. I Lipid Res 1993; 34 (26): 1-8.
35. Curtiss LK, Boisvert WA. Apolipoprotein E and atherosclerosis. Curr Opin Lipidol 2000; 11: 243-251. (Pubitemid 30336021)
36. Francoual J, Audibert F, Trioche P, Chalas J, Capel L. Is the polymorphism of the apolipoprotein E gene associated with preeclampsia? Hypertension in Pregnancy, 2002; 21 (2), Taylor &Francis.
37. Atkinson KR, Blumenstein M, Black MA, Wu SH, Kasabov N, Taylor RS et al. An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia. J Lipid Res 2009; 501:71-80.
38. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE?4 a 'thrifty' allele Ann. Hum. Genet. 1999: 63301-310.
39. Chikosi AB, Moodley J, Pegoraro RJ, Lanning PA, Rom L. Apolipoprotein E polymorphism in South African Zulu women with preeclampsia. Hypertens Pregnancy. 2000; 19(3): 309-14.
40. JiYing W, JianMin N, GuoCheng L et al. The relationship between ApoE polymorphism and pre-eclampsia. Chinese Journal of Practical Gynecology and Obstetrics 2009; 25(7): 520-522.